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Abstract
Microglia sense their environment using an array of membrane receptors. While
P2Y12 receptors are known to play a key role in targeting directed motility of micro-
glial processes to sites of damage where ATP/ADP is released, little is known about
the role of P2Y13, which transcriptome data suggest is the second most expressed
neurotransmitter receptor in microglia. We show that, in patch-clamp recordings in
acute brain slices from mice lacking P2Y13 receptors, the THIK-1 K
+ current density
evoked by ADP activating P2Y12 receptors was increased by ~50%. This increase
suggested that the P2Y12-dependent chemotaxis response should be potentiated;
however, the time needed for P2Y12-mediated convergence of microglial processes
onto an ADP-filled pipette or to a laser ablation was longer in the P2Y13
KO. Anatomical analysis showed that the density of microglia was unchanged, but
that they were less ramified with a shorter process length in the P2Y13 KO. Thus,
chemotactic processes had to grow further and so arrived later at the target, and
brain surveillance was reduced by ~30% in the knock-out. Blocking P2Y12 receptors
in brain slices from P2Y13 KO mice did not affect surveillance, demonstrating that
tonic activation of these high-affinity receptors is not needed for surveillance. Strik-
ingly, baseline interleukin-1β release was increased fivefold while release evoked by
LPS and ATP was not affected in the P2Y13 KO, and microglia in intact P2Y13 KO
brains were not detectably activated. Thus, P2Y13 receptors play a role different from
that of their close relative P2Y12 in regulating microglial morphology and function.
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1 | INTRODUCTION
Microglia are the resident immune cells of the central nervous system
(CNS), with crucial roles in both tissue development and homeostatic
maintenance. They express a wide array of membrane receptors,Vasiliki Kyrargyri and Christian Madry contributed equally to this study.
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which allow them to sense their environment and respond to patho-
logical stimuli. In the healthy brain, microglia are highly motile ramified
cells that constantly extend and retract their processes to survey the
CNS tissue (Davalos et al., 2005; Nimmerjahn, Kirchhoff, & Helmchen,
2005). We recently showed that this mode of microglial motility is regu-
lated by the membrane potential generated by tonic activity of the two-
pore domain potassium channel THIK-1 (Madry, Arancibia-Cárcamo,
et al., 2018; Madry, Kyrargyri, et al., 2018). Under pathological condi-
tions, such as brain tissue damage, disease or infection, microglia
become activated, upregulating surface receptors such as MHCII and
A2A, while their morphology becomes less ramified, with fewer,
shorter processes, and larger somata (Kreutzberg, 1996; Orr, Orr, Li,
Gross, & Traynelis, 2009). Depending on the nature of the stimuli,
microglia can also undergo a complete transformation into different
functional and morphological, for example, amoeboid, states and
secrete neurotoxic inflammatory, or neuroprotective anti-inflammatory
factors (Hanisch & Kettenmann, 2007).
ATP is a major neurotransmitter in the CNS, which is also released
by injured cells and serves as a key stimulus for triggering microglial
responses (Biber, Neumann, Inoue, & Boddeke, 2007; Burnstock,
2006; Zimmermann, 1994). Microglia detect ATP and its degradation
product ADP through the purinergic receptor P2Y12 and respond by
sending out their processes to surround regions of tissue damage: a
process called directed motility (Haynes et al., 2006). P2Y12 is a Gi-
protein-coupled receptor (GPCRs), which inhibits adenylyl cyclase
activity upon activation (Communi et al., 2001; von Kugelgen & Hoff-
mann, 2016). In addition to P2Y12 receptors, transcriptome data sug-
gest that microglia express P2Y13 receptors at levels almost as high as
for P2Y12 (Zhang et al., 2014). P2Y12 and P2Y13 receptors share a sim-
ilar pharmacology and molecular structure (48% identical at the amino
acid level; Perez-Sen et al., 2017). However, although the function of
P2Y12 receptors has extensively been studied, mainly because of its
clinical relevance to platelet-mediated thrombosis and the role of
P2Y12 in directing microglial processes to damage sites, the signifi-
cance of P2Y13 receptors for microglial function remains elusive.
Transcriptome data suggest that in the brain P2Y13 mRNA is
expressed predominantly by microglia, much less by oligodendrocyte
precursor cells and myelinating oligodendrocytes, and not by other
brain cell types (Zhang et al., 2014). A recent study supports these data
showing that microglia in the brain, and not neurons, astrocytes, or
neural progenitor cells, express P2Y13 mRNA under basal conditions,
using fluorescence in situ hybridization (Stefani et al., 2018). However,
P2Y13 protein expression may be low (Haynes et al., 2006), possibly
due to constitutive ubiquitination and proteasomal degradation (Pons
et al., 2014). P2Y13 mRNA is upregulated in pathological conditions
such as demyelination (Bedard, Tremblay, Chernomoretz, & Vallieres,
2007) and neuropathic pain (Kobayashi, Yamanaka, Yanamoto,
Okubo, & Noguchi, 2012; Niu et al., 2017), suggesting a role of this
receptor in neuroinflammation. However, its function in microglia,
especially under physiological conditions, is still unclear, although it
may evoke a rise of [Ca2+]i in response to ADP (Zeng et al., 2014) and
be involved in the release of proinflammatory cytokines (Liu et al.,
2017). Increasing evidence also supports the notion that ADP may act
through P2Y13 receptors to regulate the structural complexity of
microglia (Matyash, Zabiegalov, Wendt, Matyash, & Kettenmann,
2017; Stefani et al., 2018) and contribute to the homeostatic control of
adult hippocampal neurogenesis in situ (Stefani et al., 2018).
In this study, we expand this knowledge and describe the effect of
genetically deleting P2Y13 receptors on microglial morphology and
function in the brain. Knocking out P2Y13 results in less ramified micro-
glial cells and a reduction in brain surveillance. It also increases the
P2Y12-mediated THIK-1 current, although the directed motility (but
not the speed of individual process movements) towards an ADP
source or brain injury is slower in the P2Y13 KO mice, as the shorter
processes need to grow further and thus take a longer time to reach
their target. The membrane potential of P2Y13 KO microglia is similar
to that of WT microglia, indicating that the deramified morphology is
not due to voltage changes (Madry, Kyrargyri, et al., 2018), but has
some aspects of a “primed-like” microglial phenotype. This is further
supported by higher baseline levels of interleukin 1β release in P2Y13
KO mice. However, in the intact brain of P2Y13 KO mice, no changes
of classical microglial activation markers were detected. Together,
these findings indicate that P2Y13-deficient microglia exist neither in a
typical nonactivated nor an activated state, but that they have adopted
a partly deramified state which lies in between those two boundaries.
2 | MATERIALS AND METHODS
2.1 | Mice
Generation of the P2Y13 KO mouse strain and gross characterization
were described previously (Fabre et al., 2010). In brief, they were gen-
erated through homologous recombination of a construct in which
the first noncoding exon and 182 base pairs of the second exon of
p2ry13 were replaced with a neomycin resistance cassette to gener-
ate loss of P2Y13 expression. This construct was integrated into
embryonic stem cell genomic DNA following electroporation. Blasto-
cysts with this allele were generated and implanted into pseudopreg-
nant females. Deletion of P2Y13 in this mouse line was confirmed via
real-time PCR of liver samples. (Confirmation of the deletion of micro-
glial P2Y13 using antibody labeling or Western blots was not possible
because neither of the two commercially available P2Y13 antibodies
that we tested (Alomone APR017 and Abcam ab108444) nor the
P2Y13 antibody, that was kindly provided by David Julius, labeled
microglia (in brain slices or when isolated) or western blots of brain or
spleen tissue specifically in the wild-type mice; instead there was
labeling of cells, and multiple western blot bands, in both WT and KO
tissue (Figure S1). KO mice are healthy, fertile and show no behavioral
abnormalities. For all experiments, mice with a C57BL/6-background
(backcrossed at least 12 times) were used, and WT and P2Y13 KO
mice of either sex were age-matched and usually littermates. For
microglial imaging in real-time, for some experiments, the P2Y13 KO
mice were bred with transgenic mice expressing eGFP under control
of the Iba1 promoter (Hirasawa et al., 2005) in which microglia are
labeled by eGFP. Preweaning animals were housed with their mother
and sometimes the father as well; weaned animals were housed in
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groups of 2–5. Housing was in individually ventilated cages. Animal
procedures were carried out in accordance with the guidelines of the
UK Animals (Scientific Procedures) Act 1986 and subsequent amend-
ments, and a local ethical review board gave approval. Ages are stated
in the figure legends for each experiment.
2.2 | Brain slice preparation
Acute hippocampal slices (300 μm thick) from young animals (1–
2 months old) were prepared using an ice-cold standard slicing solu-
tion (Bischofberger, Engel, Li, Geiger, & Jonas, 2006), containing
(mM) 124 NaCl, 26 NaHCO3, 1 NaH2PO4, 2.5 KCl, 2 MgCl2, 2 CaCl2,
10 glucose, bubbled with 95% O2/5% CO2, pH 7.4, as well as 1 mM
Na-kynurenate to block glutamate receptors. Hippocampal slices from
older animals (>2 months old) were prepared using two different solu-
tions (Nortley et al., 2019; Ting, Daigle, Chen, & Feng, 2014), a protec-
tive NMDG slicing solution containing (mM) 93 N-methyl-D-
glucamine (NMDG), 93 HCl, 20 HEPES, 30 NaHCO3, 2.5 KCl, 0.5
CaCl2, 10 MgCl2, 1.2 NaH2PO4, 25 glucose, 1 kynurenic acid, 5 Na-
ascorbate, 3 Na-pyruvate, pH adjusted to 7.4 with HCL, bubbled with
95%O2/5%CO2 and cooled at <4C and a protective recovery solu-
tion containing (mM) 92 NaCl, 20 HEPES, 30 NaHCO3, 2.5 KCl,
2 CaCl2, 1 MgCl2, 1.2 NaH2PO4, 25 glucose, 1 kynurenic acid, 5 Na-
ascorbate, 3 Na-pyruvate, pH set to 7.4 with NaOH, bubbled with
95%O2/5%CO2. Immediately after slicing, slices were moved to
warmed slicing solution (33–35C) for 15 min before moving them to
the recovery solution at room temperature where they were stored
until the experiment. The kynurenic acid was added to the slicing solu-
tions to block glutamate receptors and prevent excitotoxic damage to
neurons during the slicing but it was removed from the experimental
solution as described below. At the age of 2–4 months old, P2Y13
mRNA expression is relatively high (Crain, Nikodemova, & Watters,
2009). Brain slicing does not activate microglia for at least 4 hr, as
judged by cell morphology, motility and interleukin 1β release
(Gyoneva & Traynelis, 2013; Kurpius, Wilson, Fuller, Hoffman, &
Dailey, 2006), and allows pharmacological investigation of mecha-
nisms in a manner that is not possible using in vivo experiments. For
experiments not employing Iba1-GFP mice (as stated in the main text),
slices were incubated for 30 min in darkness at room temperature
(22–24C) in oxygenated HEPES-buffered external solution (see
below) containing 25 μg/ml Alexa 594 conjugated isolectin B4
(ThermoFisher) for live imaging experiments or 25 μg/ml Alexa
568 conjugated isolectin B4 for electrophysiology experiments
(Grinberg, Milton, & Kraig, 2011; Kurpius et al., 2006), before being
used in experiments. Isolectin B4 labeling does not activate microglia
(Grinberg et al., 2011) and its use avoids functional changes which
might occur in transgenically labeled microglia.
2.3 | Solutions and electrophysiology
Slices were superfused with HEPES-buffered solution, at 34–36C for all
experiments involving imaging and at room temperature (22–24C) for
electrophysiological experiments, containing (mM) 140 NaCl, 2.5 KCl,
10 HEPES, 1 NaH2PO4, 2 CaCl2, 1 MgCl2, 10 glucose, pH set to 7.4 with
NaOH, bubbled with 100% O2. Cells were whole-cell clamped with elec-
trodes containing KCl based solution, comprising (mM) 125 KCl, 4 NaCl,
1 CaCl2, 10 HEPES, 10 EGTA, 4 MgATP, 0.5 Na2GTP, pH set to 7.1 with
KOH. The final osmolarity was 285 ± 5 mOsmol/kg. Microglia were iden-
tified by their fluorescent label and ramified morphology, and whole-cell
clamped at a depth of ~50–100 μm in the slice using borosilicate pipettes
with a tip resistance of ~4–5 MΩ, giving a series resistance of <20 MΩ.
Electrode junction potentials were compensated. I–V relations were from
responses to 200 msec voltage steps ranging from −124 mV to +56 mV
in 30 mV increments. Voltage- and current-clamp recordings were per-
formed using a MultiClamp 700B amplifier (Molecular Devices). Currents
were filtered at 1 kHz, digitized (10 kHz) and analyzed off-line using
pClamp10 software.
2.4 | Two-photon imaging and evoked directed
motility
Microglia in hippocampal slices were imaged at 34–36C, at a depth of
~50–100 μm in the slice (to avoid studying superficial microglia that
had started to become activated by the slicing procedure) using a Zeiss
LSM 710 or 780 microscope (with a 20X lens, NA 1.0) and a Spec-
traphysics Mai Tai DeepSee eHP Ti:sapphire infrared laser. For imaging
of microglia labeled with isolectin B4-Alexa 594, the laser was tuned to
a wavelength of 800 nm, while for imaging cells labeled with eGFP a
wavelength of 920 nm was used with a pixel dwell time of 1 μs. Gener-
ally the laser was adjusted to 1.8% of its maximum power at 800 nm or
6–8% at 920 nm, corresponding to ~5 mW and ~12 mW, respectively,
at the preparation, that is, well within the intensities used by others
(Hines, Hines, Mulligan, & Macvicar, 2009; Pfeiffer, Avignone, & Nagerl,
2016; Wake, Moorhouse, Jinno, Kohsaka, & Nabekura, 2009).
Ablation of a small volume of tissue (laser damage) was performed
by illuminating a ~10 μm radius spot with the laser intensity increased
30-fold and the pixel dwell time increased to 100 μs. For imaging of
directed process motility in response to a pipette filled with 1 mM
ADP or to a laser ablation, stacks of 21–31 slices imaged at 2 μm
depth intervals were acquired every 30 s (the image analysis was per-
formed to maximum intensity of stacks having a total z-dimension of
12 μm as described below). For imaging of microglial surveillance, sta-
cks of 21–31 slices imaged at 2 μm depth intervals were acquired
every 60 s. Images were typically 512 by 512 pixels and covered a
square field of view 200–250 μm wide.
2.5 | Image analysis
Analysis of two-photon images was performed using custom-written
ImageJ (NIH) and MATLAB scripts, available at https://github.com/
AttwellLab/Microglia. For analysis and quantification of microglial sur-
veillance, each slice of every stack was filtered with a median filter
after subtraction of smooth continuous background with the ImageJ
“subtract background” plugin with a ball size of 30 pixels. The 4D sta-
cks were then registered first for lateral drift, then rotated 90 on
their side, registered for z-drift and rotated back to their original
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orientation. We then performed a maximum intensity projection. Cells
of interest were individually selected by manually drawing a region of
interest (ROI) around an area including all their process extensions
over the whole duration of the resulting 2D movie, and erasing data
around that ROI. These 2D movies of individual cells were then manu-
ally binarized and saved as independent files. The binarization was
performed on high resolution and preprocessed images with the
experimenter blinded to the genotype. The choice of the threshold
value was based on the intensity and morphology of the cells. As a
general binarization criterion, the threshold value was set to a value
ensuring that all the microglial processes, even the thinner ones, were
visible in all the different time frames.
To quantify surveillance, for each movie, starting with the second
frame, we subtracted from each binarized frame Ft the preceding frame
Ft − 1 and created two binarized movies, PE consisting of only the pixels
containing process extensions (Ft − Ft − 1 > 0) and PR consisting of only
the pixels containing process retractions (Ft − Ft − 1 < 0). In both PE and
PR, all other pixels are set to 0. The surveillance index B is defined as
the sum over all nonzero pixels in PE + PR, that is:
B=Σpixels PE +PRð Þ
where Σpixels denotes a sum taken over all nonzero pixels, and in most
graphs is displayed normalized to its average over the first 20 min of
the experiment (<Σpixels [PE + PR] > control where < >control denotes a
temporal average taken over the 20-min control period of the experi-
ment), or normalized to the value for WT mice. The surveillance index
provides a measure of the brain volume that is surveyed by a micro-
glial cell in a given time. It is affected both by the rate at which pro-
cesses elongate and shorten, and by the overall number of the
microglial processes and their length.
To quantify ramification, the resulting movies were processed
using MATLAB. In each movie frame, the MATLAB functions bwarea
(uk.mathworks.com/help/images/ref/bwarea.html) and bwperim (uk.
mathworks.com/help/images/ref/bwperim.html) with 8-connected
neighborhood were used to quantify, respectively, the area and the
perimeter of the cell. The ramification index R is defined as the ratio
of the perimeter to the area, normalized by that same ratio calculated
for a circle of the same area. Specifically:
R= perimeter=areað Þ= 2: π=areað Þ1=2
h i
:
Thus, R = 1 if the cell is a perfect circle. The more ramified the cell,
the larger R is.
To quantify the area-normalized motility index, a measure of how
well the cell surveys the brain given its size, we normalized the sur-
veillance index of each individual cell to its mean area. The area of
each cell was measured in maximum intensity projections for every
time frame and then averaged over all time frames to get the mean
area (in pixels) per cell. We then averaged the ratios (surveillance
index/mean area) of all cells for the WT and all cells for the KO mice
and reported these numbers.
For analysis and quantification of microglial directed process
motility in response to a laser ablation to simulate brain injury, or to a
pipette filled with 1 mM ADP, each slice of every stack was first fil-
tered with a median filter (which replaces each pixel value with the
median value of the 3 pixel × 3 pixel array centered on that pixel). We
then performed a maximum intensity projection of stacks having a
total z-dimension of 12 μm (with the pipette tip or the laser ablation
in the middle), registered (Thevenaz, Ruttimann, & Unser, 1998), and
binarized the resulting two-dimensional movies (setting the threshold
for binarization manually). The resulting movies were processed using
a MATLAB script inspired by the algorithm described by Gyoneva
et al. (2014). Briefly, after the user manually clicks on the final target
of chemotactic processes (the tip of the glass pipette containing ADP),
the algorithm divides the surrounding area into concentric circles with
radii at 2 μm intervals, and then segments these circles into 32 radial
sectors, thus creating 32 patches between every two consecutive
concentric circles. Then, for each frame, starting from the center, the
algorithm searches in every radial sector for the first patch containing
>10 positive pixels (labeled microglia). The outputs of the algorithm
are, for each frame, (a) the surface area contained within the converg-
ing microglial process front (Figure 4a,c) and (b) the distance to the
microglial process front in each sector (Figure 4b,d). To estimate the
speed of individual process movements (for Figure 4g), in each sector
the rate of approach (in μm/30 s) of the microglial processes was cal-
culated for 30 s time bins, averaged over all sectors to obtain an aver-
age for that cell and time bin, and then averaged over all time bins
during the convergence process (until no further convergence was
observed) for that cell, and then averaged over all cells.
2.6 | Microglia immunostaining and Sholl analysis
Microglial morphology was assessed by Sholl analysis (Sholl, 1953). To
compare changes in microglial morphology produced by deletion of
P2Y13 expression, three KO and three control wild-type (WT) mice
were killed by sodium-pentobarbital overdose and fixed by trans-
cardial perfusion with 4% paraformaldehyde (PFA). Brains were then
removed and further fixed for 24 hr in 4% PFA. Horizontal sections
(75 μm, “magic cut”; Bischofberger et al., 2006) were cut on a
vibratome (Leica). Tissue sections were blocked and permeabilized in
10% goat serum and 0.5% Triton X-100 in PBS for 4 hr at room tem-
perature. Slices were incubated at 4C overnight in rabbit anti-Iba1
(Synaptic Systems 234003) antibody prepared in blocking solution.
After washing three times for 20 min in PBS, slices were incubated
overnight in secondary antibody (goat anti-rabbit Alexa Fluor 488).
Slices were then washed in PBS, incubated in DAPI (Invitrogen) and
mounted on glass slides using DAKO fluorescence mounting medium.
All images were acquired using a 63× oil immersion objective (NA 1.4)
on a Zeiss LSM700 confocal microscope. All analysis was carried out
with the experimenter blinded to the genotype. Cell reconstructions
were carried out using 3D automatic cell tracing in Vaa3D software
(http://www.vaa3d.org), which is available online and uses the APP2
(all-path-pruning 2.0) algorithm to re-construct ramified cells in 3D
(Xiao & Peng, 2013). In brief, the algorithm uses the gray-weighted
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image distance transform (https://uk.mathworks.com/help/images/
ref/graydist.html) to assess the area occupied by the cell. This can be
done either automatically or manually. It then allows the experimenter
to manually perform a background thresholding method and applies
the distance transform algorithm to specify the cell body as the main
seed node. It subsequently reconstructs a “tree” where the seed node
is the cell body, the branch nodes are the microglial branches that
connect different processes (segments) and the leaf nodes are the ter-
minals. It then applies a length-based hierarchical pruning method to
code the final reconstruction of the cell. Finally, the tracing method
produces a file with all the hierarchical information stored and mor-
phological parameters are then extracted using custom code written
in MATLAB. The code used is available at https://github.com/
AttwellLab/Microglia.
2.7 | P2Y13 immunohistochemistry
Fluorescent immunohistochemistry was performed on vibratome hip-
pocampal slices (70 μm) from perfusion-fixed WT and P2Y13 KO mice
(Figure S1a). Slices were initially incubated in antigen retrieval solution
containing 10 mM Na citrate and 0.05% Tween20, pH 6 at 90C for
20 min. The slices were then washed three times in PBS, blocked and
permeabilized in 10% horse serum and 0.5% Triton X-100 in PBS for
2 hr at room temperature and incubated in primary antibodies to rab-
bit P2Y13 (1:20, APR017, Alomone Labs) and to chicken Iba1 (1:500,
Novus biologicals) overnight at 4C. The slices were then washed
three times in PBS for 20 min and incubated in secondary antibodies
(1:1,000, donkey anti-rabbit Alexa-Fluor 568 and donkey anti-chicken
Alexa Fluor 488). Slices were then washed in PBS, incubated in DAPI
(Invitrogen) and mounted on glass slides using DAKO fluorescence
mounting medium.
DAB Immunohistochemistry was performed on brain paraffin
sections (5 μm) from WT and P2Y13 KO mice to detect P2Y13 pro-
tein expression in situ (Figure S1d–f). The sections were initially de-
paraffinized in xylene and re-hydrated in a descending ethanol
series (100, 96, 70, and 50%) and dH2O. Endogenous peroxidase
activity was blocked by incubation of the slides in methanol/0.2%
H2O2 for 30 min. Antigen retrieval was performed in a food steamer
with 10 mM Tris/1 mM EDTA buffer (pH 8.5) for 20 min. The slices
were then washed in PBS, blocked in 10% FBS in PBS (blocking
buffer) for 1 hr at room temperature and incubated in primary rab-
bit anti-P2Y13 (that was kindly provided by Prof Julius lab, UCSF)
overnight at 4C. The sections were then washed in PBS and incu-
bated with biotinylated anti-rabbit secondary antibody (1:1,000 in
blocking buffer, Vector Laboratories) for 1 hr, at room temperature.
After washing in PBS, an avidin–biotin complex was used for
detection of the biotinylated antibodies and immune complexes
were visualized by brief incubation of the slices in 3,30-
diaminobenzidine tetrachloride (DAB; both from Vector Laborato-
ries). Nuclei counterstaining was performed using Mayers Hematox-
ylin (Abcam).
2.8 | Microglia isolation from adult mouse brain and
immunocytochemistry
Microglia isolation from adult mice was performed following the pro-
tocol described in Lee and Tansey (2013). In brief, three adult WT and
three adult KO mice were perfused with ice-cold sterile PBS under
deep anesthesia (sodium pentobarbital). Mice were then killed and
brains removed and finely minced with a blade on ice, followed by
incubation of the tissues in dissociation medium containing DNase I
(20 U/ml, Invitrogen), Dispase II (1.2 U/ml, Roche), and Papain
(1 mg/ml, Sigma-Aldrich) for 30 min at 37C. Tissues were subse-
quently mechanically dissociated (with the use of Pasteur pipettes)
and filtered into single-cell suspensions before being centrifuged at
250 g for 4 min. The cell pellets were then re-suspended in 37% isotonic
Percoll (4 ml per brain) and loaded into 15 ml conical tubes in between
30 and 70% layers of Percoll. The Percoll gradients were then cen-
trifuged at 300g for 40 min at 18C. The 70–37% interfaces, that
included microglia, were collected, diluted in HBSS (1×, Sigma Aldrich)
and centrifuged at 500g for 7 min at 4C. The pellets were re-suspended
in HBSS, washed three times and then seeded on poly-L-lysine precoated
coverslips in 24-well plates and used for immunocytochemistry.
For double immunofluorescence, WT and P2Y13 KO cells were
fixed with 4% PFA for 20 min at 4C, washed three times in PBS,
blocked and permeabilized in 10% horse serum and 0.5% Triton X-
100 in PBS for 4 hr at room temperature and incubated in primary
antibodies rabbit P2Y13 (1:20, APR017, Alomone Labs) and goat Iba1
(1:50, Novus Biologicals) overnight at 4C. The cells were then
washed 3 times in PBS and incubated in secondary antibodies (donkey
anti-rabbit Alexa Fluor 568 and donkey anti-goat Alexa Fluor 488) for
1 hr at room temperature. Cells were then washed in PBS, incubated
in DAPI (Invitrogen) and mounted on glass slides using DAKO fluores-
cence mounting medium. All images were acquired using a 63× oil
immersion objective (NA 1.4) on a Zeiss LSM700 confocal
microscope.
2.9 | ELISA measurements of interleukin-1β and
TNFα release
As previously described (Charolidi, Schilling, & Eder, 2015; Madry,
Kyrargyri, et al., 2018), hippocampal slices (300 μm thick) were pre-
pared in ice-cold HEPES-buffered medium (MEM bubbled with O2,
pH 7.4, 42360-032, Gibco) under sterile conditions. To induce
inflammasome activation and IL-1β release, slices were exposed to
inflammatory-like stimuli (Bernardino et al., 2008). Each slice was
placed on a Millicell cell culture insert (12 μm pore size, PIXP01250,
Merck Millipore) and transferred into 24-well plates containing 800 μl
serum-free medium (DMEM, pH 7.4, 41,965–039, Gibco) with or
without lipopolysaccharide (LPS; 50 μg/ml, Escherichia coli 055:B5,
L2880, Sigma-Aldrich) in a cell culture incubator at 37C. After
30 min, the medium above the slices was removed and slices were
kept for 6 hr in 350 μl DMEM with or without LPS, for the last 3 hr of
which 1 mM ATP was added (or not), as indicated. The concentrations
of LPS used were chosen to evoke reliably detectable release of IL-1β,
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and are similar with those that have been described in the literature
to induce inflammatory response for mice (Hines, Choi, Hines, Phil-
lips, & MacVicar, 2013). The amounts of IL-1β and TNFα released into
the medium were measured by ELISA, using mouse Quantikine IL-1
beta/IL-1F2 (R&D Systems MLB00C) and mouse TNFα Quantikine
(MTA00B) kits, respectively. Data were from at least three mice per
experiment, from each of which two brain slices were used per experi-
mental condition. Immediately after collecting the media, photographs
of slices were taken and the slice surface area was determined using
Image J. To compare data between brain slices in different conditions,
the amounts of IL-1β and TNFα released into the medium were nor-
malized to the slice surface area. The data were then further normal-
ized to the mean of the control values obtained in WT mice.
2.10 | RNA isolation and quantitative RT-PCR
Total RNA was extracted from whole-brain tissues using TRIzol
(Invitrogen, Paisley, UK) according to the manufacturer's instructions.
DNAse-treated RNA samples were analyzed by quantitative RT-PCR
using QuantiFast™ SYBRVR green RT-PCR kit (Qiagen Inc.) according
to the manufacturer's instructions. All reactions were performed using
a LightCycler (Roche, Mannheim, Germany). At the end of each PCR
run, melting curve analysis was performed to verify the integrity and
homogeneity of PCR products. Gene expression levels were calcu-
lated using standard curves for each gene, which were created by
plotting threshold cycle (CT) values versus the logarithm of serial-
diluted RNA concentrations. A least-square method was used for the
determination of A and B values in the equation CT = A*Log (CRNA)
+ B. The coefficient of determination (R2) was greater than 0.99.
Values were normalized using the respective values for the house-
keeping gene, Gapdh. All results were analyzed using the LightCycler
software version 3.5 (Roche, Mannheim, Germany, RRID:
rid_000088). QuantiTect Primer Assays were used for Il6
(Mm_Il6_1_SG), Il1b (Mm_Il1b_2_SG), tlr2 (Mm_Tlr2_1_SG), Csf1
(Mm_Csf1_2_SG), Lgals3 (Mm_Lgals3_1_SG), P2ry12
(Mm_P2ry12_3_SG), Nos1 (Mm_Nos1_2_SG), and Gapdh
(Mm_Gapdh_3_SG), all QuantiTect Primer Assays from Qiagen.
2.11 | Western blot
Twenty micrograms of total protein extract from whole brain and
spleen tissues were resolved on NuPAGE 4–12% Novex Bis-Tris Gels
(Invitrogen, NP0321) and transferred onto nitrocellulose membranes.
Blots were probed with antibodies to P2Y12 (kindly provided by
Dr. David Julius, UCSF) and to P2Y13 (Abcam, ab108444) followed by
horseradish peroxidase-conjugated goat anti-rabbit IgG secondary
antibody (1:2,000, Thermo Fisher Scientific, 65-6120). Antibody bind-
ing was detected using the Luminata Crescendo Western HRP sub-
strate (Sigma, WBLUR0500). To normalize for protein content,
membranes were stripped and re-probed with anti-actin antibody
(1:5,000, Sigma, A2066). Quantification of the protein expression level
was done with ImageJ software using the built-in Gel Analysis
protocol.
2.12 | Statistics
Data are presented as mean ± SEM. p values are from two-tailed Stu-
dent's t tests (for normally distributed data) or Mann–Whitney U tests
(for non-normally distributed data). Normality of data was checked using
the Kolmogorov–Smirnov or Shapiro–Wilk test and equality of variance
confirmed using the F-test. Sholl analysis distributions were compared
with a Kolmogorov–Smirnov test. For multiple comparisons, p values
are corrected using a procedure equivalent to the Holm–Bonferroni
method (for N comparisons, the most significant p value is multiplied by
N, the second most significant by N − 1, the third most significant by
N − 2, etc.; corrected p values are significant if they are <0.05).
3 | RESULTS
3.1 | P2Y13 receptor knock out decreases microglial
ramification and surveillance
To test for an effect of knocking out P2Y13 receptors on microglial
morphology, we perfusion fixed adult wild-type (WT) and P2Y13 KO
mice, immuno-labeled microglia for Iba-1 in hippocampal slices, and
quantified their process ramification by performing a three-dimensional
Sholl analysis. Individual cells were analyzed in high-resolution confocal
image stacks. While the microglial density was similar in the wild type
and knock-out mice (Figure 1a,b), their morphology was significantly
different. The P2Y13 KO microglia displayed a much less ramified mor-
phology (Figure 1c), with shorter and fewer complex processes
(Figure 1d), covering less volume than their WT counterparts. Sholl
analysis-derived quantification showed that knocking out P2Y13 recep-
tors reduced the number of intersections of microglial processes with
concentric Sholl spheres at increasing distances from the soma
(Figure 1e), and reduced numbers of process terminals (tips; Figure 1f)
and branch points (Figure 1g). Thus, microglia without P2Y13 receptors
show a less complex morphology, with fewer and shorter processes
compared to their wild-type counterparts.
To investigate how microglial surveillance is affected by knocking
out P2Y13 receptors, we live-imaged microglia genetically labeled with
eGFP in hippocampal slices from WT and P2Y13 KO mice using two-
photon microscopy, and quantified changes of surveillance minute-by-
minute (see section 2). Experiments were carried out less than 4 hr
after brain slicing, on microglial cells located 50–100 μm deep in the
slice, to avoid microglial activation (Hanisch & Kettenmann, 2007;
Kurpius et al., 2006). Briefly, the surveillance index is a measure of the
number of image pixels surveyed per unit time and depends on both
the number of cell processes and their speed of movement. Knocking
out P2Y13 receptors significantly reduced surveillance of the brain by
microglia (Figure 2a,b). Plotting the time course of the increase in sur-
veyed area in maximum intensity projections showed that the initial
rate of surveillance was reduced by 23% (p = .009), and the cumulative
area (in maximum intensity projections) surveyed after 20 min was
reduced by 21% (p = .005) in the P2Y13 KO mice (Figure 2c,d; Movie
S1). This decrease in surveillance may, at least in part, reflect the fact
that microglia in P2Y13 KO mice are less branched and/or less motile
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F IGURE 1 Effect of P2Y13 receptor knock-out on microglial morphology and density in hippocampal slices. (a) Specimen images of perfusion-
fixed P90 wild-type (WT) and P2Y13 knock-out (KO) hippocampal slices labeled for Iba1 show that microglial density appears unchanged in the
KO. (b) Microglial density in the strata radiatum and lacunosum/moleculare of areas CA1–CA3 of 12 WT and 12 KO hippocampal slices (from
4 WT and 4 KO P90 animals). Numbers of slices are on bars. (c–g) Ramification analysis of microglia from perfusion-fixed WT (25 cells at P59–
P135) and P2Y13 KO (29 cells at P53–P127) mice, showing (c) representative 3D-reconstructed P59 WT and P53 KO microglia, and (d–g) Sholl
analysis derived: (d) total process length; (e) number of process intersections with shells at distances (in 5 μm increments) from the soma; (f)
number of process terminal points (tips); and (g) number of branches [Color figure can be viewed at wileyonlinelibrary.com]
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than in WT mice. Analyzing the ramification index—a measure of the
ratio of the cell's perimeter to its area (normalized to that of a circle of
the same area) which depends on the cell's shape but not on its overall
size (Madry, Kyrargyri, et al., 2018)—showed that KO cells had a ramifi-
cation index that was 11% smaller (p = .01) than WT cells. Further
analysis of the cell size-independent motility index—derived by
normalizing the surveillance index to the mean area of each cell—
showed that the KO cells, despite being less ramified, are as motile
as the WT ones (motility index KO: 0.153 ± 0.008 and WT: 0.162
± 0.007; p = .477). Thus, the decreased surveillance of the P2Y13
KO microglial cells largely arises from their decreased ramification.
To test whether these effects may originate from elevated cAMP
levels due to the disruption of the major P2Y13-gated Gi-protein
coupled signaling pathway (Bernier et al., 2019), while imaging WT
brain slices we applied forskolin, which activates adenylate cyclase
and raises cAMP. This reduced surveillance by 43% (p = 1.2 × 10−9,
Figure S2a,c,d) and ramification by 22% (p = 3.5 × 10−11, Figure S2a,e,f),
suggesting that the altered morphology and surveillance of P2Y13 KO
microglia, which resemble what occurs after forskolin treatment in WT
slices, may be mediated by a rise in cAMP levels.
These results show that microglia in mice without P2Y13 receptors
are less ramified than microglia in WT mice, and survey less brain
F IGURE 2 Effect of P2Y13 receptor
knock-out on microglial surveillance in
hippocampal slices. (a) Specimen images
taken 5 min apart of P85 WT and P88
P2Y13 KO Iba1-eGFP microglia, showing
process extensions and retractions
(red = retracted, green = extended
processes) and the less ramified shape of
microglia in the KO. (b) Quantification of
surveillance for microglia from 3 WT and
3 KO mice, showing less surveillance in
the KO than in their WT littermates.
(c) Time course of increase of the number
of surveyed pixels in maximum intensity
projections of images of microglia in WT
and KO Iba1-eGFP mice. Initial value is
the area of the cell in the first image
frame. (d) Initial slope of graphs in c
(measured over the first 2 min, when
assessment of surveillance is least
confounded by pixel overlap in the
maximum intensity projection. (e) Time
course of surveillance indices with no
drugs (no PSB-0739) in 3 WT mice or
with application after 20 min of PSB-
0739 (PSB) to block P2Y12 receptors in
3 WT and 3 KO Iba1-GFP hippocampal
slices. Data show less surveillance in the
KO and no significant effect of PSB. Data
are normalized to the mean baseline
values of the WT mice (averaged over the
period from 1 to 19 min). (f)
Quantification of the normalized
surveillance index in the presence of PSB-
0739, calculated as the mean surveillance
index in PSB-0739 (averaged over the last
5 min in the drug) relative to the mean
baseline surveillance index (averaged over
the last 5 min of the baseline). The value
shown for the Control bar is obtained
from data at the same times as for the
slices to which PSB-0739 was applied, but
for the WT slices to which no PSB was
applied. Age for b–f was P85–P119 for
WT and P88–P131 for KO. Number of
microglia shown on bars; p values were
from t tests [Color figure can be viewed at
wileyonlinelibrary.com]
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volume per unit time than their wild-type counterparts, thus requiring
a longer time to survey a given brain volume.
3.2 | Microglial surveillance still occurs in the
absence of P2Y12 and P2Y13 function
We have recently shown that short-term block of P2Y12 receptors
with the selective antagonist PSB-0739 does not alter surveillance of
the brain by microglia, implying that the normal level of ADP in the
extracellular space of brain slices is too low to activate P2Y12 recep-
tors (Madry, Kyrargyri, et al., 2018). P2Y13 receptors have a similar
affinity for ADP (Abbracchio et al., 2006), and so are also not
expected to be activated by ambient ATP/ADP levels. Nevertheless,
to test whether physiological levels of ATP/ADP in the brain can regu-
late surveillance through P2Y13, we first imaged microglial cells in
slices of WT and P2Y13 KO mice in the presence of MRS 2211
F IGURE 3 P2Y13 knock-out increases ATP-evoked membrane current changes but not tonic activity of THIK-1 K
+ channels. (a) Specimen
current responses of microglia in WT and P2Y13 KO hippocampal slices to voltage steps between −124 and +56 mV, from a holding potential of
−34 mV. (b) Mean steady-state I–V relations from data as in (a) from 10 WT and 12 KO cells. (c) Peak outward current evoked at 0 mV in WT and
KO microglia by puffing 100 μM ADP above the slice. (d) Mean ADP-evoked current density (number of cells on bars). (e–g) Mean cell
capacitance (e) resting potential (f), tetrapentylammonium-suppressed tonic THIK-1 current density (g), and input resistance (h) in WT and KO
cells (numbers of cells on bars). All data from P60-120 littermate-matched mice
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(25 μM), a commonly used antagonist for P2Y13 receptors, and mea-
sured their surveillance and ramification. We found that MRS 2211
reduced both parameters in wild-type microglia, but surprisingly also
reduced them (by a similar amount) in P2Y13 KO microglia (Figure S3a,
b). This is inconsistent with the suppression of surveillance being
mediated by block of P2Y13 receptors. Indeed, MRS 2211, which is a
competitive antagonist of P2Y13 receptors (pIC50 = 5.97, in the pres-
ence of 100 nM ADP) is also an antagonist, albeit 20-fold less power-
ful (Kim et al., 2005), for P2Y12 receptors and for P2Y1 receptors
(expressed by neurons and astrocytes; Zhang et al., 2014). However,
neither activation nor blockade of P2Y1 receptors, by applying MRS
2365 (10 μM) and MRS 2179 (25 μM), respectively, altered surveil-
lance (see Figure S4a,c), while MRS 2365 weakly reduced ramification
(Figure S4b,d). These data, in combination with the lack of effect on
surveillance of the P2Y12 receptor blocker PSB-0739 (Madry,
Kyrargyri, et al., 2018), imply that the MRS 2211-evoked effects do
not reflect an action on P2Y1 or P2Y12 receptors.
We considered the possibility that P2Y13 and P2Y12 might affect
each other's expression, or form dimers and act cooperatively perhaps
because each receptor affects the trafficking of the other to the cell
surface membrane (see next section) or because of a need for ADP to
bind to both P2Y12 and P2Y13 (assuming a dimeric receptor) for recep-
tor activation to occur. We initially quantified the total P2Y12 protein
level in the P2Y13 KO brain tissue by western blot and found that it
was not significantly different compared to the WT tissue (Figure S5a,
b). Immunohistochemistry with a P2Y12 antibody also showed that its
protein distribution in the P2Y13 KO microglia in fixed hippocampal
slices was broadly similar to that in wild-type microglia (Figure S5c).
To test the effect on microglial surveillance of blocking both P2Y12
and P2Y13 receptor function, we applied the selective P2Y12 antago-
nist PSB-0739 to P2Y13 KO slices and quantified any change in sur-
veillance index that occurred. Blocking P2Y12 receptors with PSB-
0739 (2 μM) did not significantly affect surveillance of microglia in the
P2Y13 KO or WT (Figure 2e,f). This confirms our previous finding that
the physiological levels of ATP and ADP in the brain are too low to
affect microglial surveillance by activating P2Y12 receptors (Madry,
Arancibia-Cárcamo, et al., 2018; Madry, Kyrargyri, et al., 2018) and
presumably also P2Y13 receptors, which have a similar high affinity for
ADP (Abbracchio et al., 2006).
In summary, knocking out P2Y13 receptors reduces microglial ram-
ification and thus surveillance of the brain. These effects were also
seen with the supposedly specific P2Y13 blocker MRS 2211, but MRS
2211 also had this effect in the P2Y13 KO and so acts by a mechanism
not involving P2Y13 receptors. Surveillance still occurred with P2Y12
receptors blocked in the P2Y13 knock-out, implying that no purinergic
stimulation of either of these receptors is needed for microglial sur-
veillance to occur.
3.3 | Microglia lacking P2Y13 receptors show a
normal resting potential but a larger ADP-evoked K+
current
To test whether the effect of knocking out P2Y13 receptors on ramifi-
cation and surveillance was mediated by changes of the membrane
potential, as found previously when blocking THIK-1 K+ channels in
the microglial membrane (Madry, Kyrargyri, et al., 2018), we per-
formed whole-cell patch-clamp experiments on microglia labeled with
fluorescently tagged isolectin B4 in situ in acute WT and P2Y13 KO
mouse hippocampal slices.
Both WT and P2Y13 KO microglia had a resting potential of
~ −40 mV and showed an approximately linear I–V relation with slight
outward rectification, indicating the absence of voltage-dependent
conductances (Figure 3a,b). Applying ADP from a puff pipette (con-
taining 100 μM ADP) located above the slice evoked an outward cur-
rent at 0 mV as reported previously (Madry, Kyrargyri, et al., 2018),
however in the P2Y13 KO the current density was ~50% larger
(Figure 3c,d). The ADP-evoked current reflects the activation of
THIK-1 K+ channels by ADP binding to P2Y12 receptors but THIK-1
channels are also tonically active and thus set the resting potential
(Madry, Kyrargyri, et al., 2018). Despite the increase of the ADP-
evoked current in the P2Y13 KO, the tonic activity of THIK-1 was
unaffected, since the resting potential, the tetrapentylammonium
(TPA) sensitive tonic THIK-1 current component and the input resis-
tance of the cells were all unaffected by KO of P2Y13 (as was the cell
capacitance: Figure 3e–h, which may reflect an increase in process
diameter compensating for shorter process length). This suggests that
deleting P2Y13 increases the function of P2Y12 receptors (as assessed
by their coupling to THIK-1: see section 4). The enhanced P2Y12
receptor signaling in the P2Y13 KO might suggest that damage-evoked
F IGURE 4 Effect of P2Y13 receptor knock-out on microglial directed motility in hippocampal slices. (a-b) Directed motility to an ATP-filled
pipette. (a) Time course of directed motility quantified as reduction of the “clear area” not occupied by microglia around the 1 mM ADP-filled
pipette tip in 6 WT and 5 KO mice. (b) Time course of directed motility quantified as reduction of the mean distance (μm, averaged over sectors)
from the microglial processes to the ADP-filled pipette tip in 6 WT and 5 KO mice. (c,d) Directed motility to a laser ablation. (c) Time course of
directed motility quantified as reduction of the “clear area” not occupied by microglia around the ablation site in 3 WT and 3 KO mice. (d) Time
course of directed motility quantified as reduction of the mean distance (μm, averaged over sectors) from the microglial processes to the ablation
site in three WT and three KO mice. (e) Time course of directed motility quantified as reduction of the normalized “clear area” around the ADP-
filled pipette in 6 WT and 5 KO mice and around the laser ablation site in 3 WT and 3 KO mice. The values were normalized to the initial “clear
area” values of each recording. (f) Quantification of the time needed for the plots in (e) to drop to the 1/e value, that is, the time needed for the
“clear area” to drop 36.7% of the initial area. (g) Quantification of the speed of convergence of the WT and KO microglial processes onto the tip
of the pipette and the laser ablation site, calculated as the distance (μm) moved per 30 sec, averaged over the period needed to converge on the
pipette tip or the ablation site, and then averaged over all the slices. Number of slices are shown on bars. Age for pipette experiments (a, b, e–g)
was P55–P121 for WT and P56–P136 for KO and for laser ablation experiments (c, d, e–g) was around P60
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ATP/ADP release and activation of P2Y12 receptors should more
effectively attract microglial processes to a damage site (Haynes et al.,
2006), but in fact this did not occur as the chemotactic response was
attenuated in the KO (see below).
To test whether the larger ADP-evoked THIK-1 currents may reflect
a raised cAMP level when P2Y13 receptors are knocked out (see above),
we perfused WT microglial cells for ~10 min with cAMP via the patch
solution, which enhanced the ADP-evoked current density by >70%
(n = 9; p = .017: see Figure S2b). This suggests that the larger ADP-
evoked THIK-1 currents of P2Y13 KO microglia may be mediated via ele-
vated cAMP levels, in line with cAMP mimicking the reduced morphology
and surveillance seen in P2Y13 KO microglia (Figure S2a,c–f).
3.4 | P2Y13 receptors regulate the rate of microglial
directed motility
To investigate a possible effect of P2Y13 receptors on microglial
directed motility, we imaged slices with two-photon microscopy in
acute hippocampal slices prelabeled with fluorescently tagged iso-
lectin B4 (see section 2). Inserting a 1 mM ADP filled glass pipette
(with a tip diameter of ~2–3 μm) carefully into the slices induced
directed motility of microglial processes to the tip of the pipette. This
resulted in complete process convergence on the tip of the pipette in
both WT and P2Y13 KO slices (Figure 4a,b), however the time needed
for the convergence of P2Y13 KO microglial processes (time to 1/e)
was 46% longer than for their WT counterparts (p = .04, Figure 4e,f).
We also evoked directed motility in slices of both genotypes in
response to focal brain injury by applying a laser ablation of ~10 μm
diameter (Figure 4c,d). The two methods initiated similar microglial
responses but with different kinetics (Figure 4a–d). The laser ablation
induced an overall faster microglial response with the complete con-
vergence of processes occurring ~8 min after the ablation, while a
chemotaxis induced by locally elevating ADP through a glass pipette
took ~15 min (Movie S2). Microglial processes took 22% longer to
arrive at the ablation site when P2Y13 was knocked out (p = .05,
Figure 4e,f). Analysis of the processing speed revealed no differences
between the WT and the KO (Figure 4g).
Overall, our results show that P2Y13 receptors are necessary to
maintain an efficient chemotactic response of microglial processes to
CNS injury.
3.5 | P2Y13 receptors reduce the resting level of
interleukin 1β release
IL-1β and TNFα are two major pro-inflammatory cytokines generated
in response to infection and contribute to tissue injury during disease.
The production of IL-1β from innate immune cells such as macro-
phages and microglia requires the formation of inflammasome com-
plexes to activate caspase 1, which generates IL-1β from its inactive
precursor. Inflammasome assembly is a multi-stage process, involving
priming by a Toll-Like Receptor agonist such as the bacterial coat
component lipopolysaccharide (LPS), followed by a fall of intracellular
[K+] evoked by an activating signal such as ATP (Munoz-Planillo et al.,
2013). We have previously shown that, in combination with priming
by LPS, activation of P2Y12 and P2Y13 receptors with 2-MeSADP
leads to inflammasome-mediated production of interleukin-1β: a pro-
cess in which P2Y12 receptors presumably evoke K
+ loss through the
activation of THIK-1 K+ channels (Madry, Kyrargyri, et al., 2018).
To determine whether P2Y13 receptors play a role in the genera-
tion and release of immune mediators when microglia become acti-
vated we used acute hippocampal slices from wild type and P2Y13 KO
mice and quantified (by ELISA) the level of the released IL-1β in the
supernatant (see section 2). Applying LPS (50 μg/ml) for 6 hr evoked
some IL-1β release, which was greatly enhanced when co-applied with
ATP for the last 3 hr of LPS exposure, both in WT and P2Y13 KO brain
slices (Figure 5a). In the KO, IL-1β release evoked by LPS and ATP
was slightly but not significantly higher than in the WT. However, the
level of baseline IL-1β release in the absence of added LPS or ATP,
was significantly higher in P2Y13 KO slices than in WT slices
(Figure 5a), suggesting that P2Y13 receptors suppress the release of
IL-1β in baseline conditions. This may also suggest that microglia
exhibit a different functional phenotype under resting conditions,
however, P2Y13 KO microglia did not appear to be activated in the
intact brain as judged by their cell body area (Davis, Salinas-Navarro,
Cordeiro, Moons, & De Groef, 2017; Gyoneva et al., 2014), which was
50.6 ± 3.78 μm2 in the WT and 47.0 ± 1.7 μm2 in the KO.
We further tested whether the release of another cytokine, TNFα,
is affected when P2Y13 receptors are deleted using the same proce-
dure as for IL-1β. TNFα is a proinflammatory cytokine, which is
released by glial cells in the brain (mainly microglia and astrocytes) in
response to pathogen- or damage-associated molecular patterns, in a
process that does not require inflammasome assembly (and so presum-
ably does not require K+ loss from the cell via THIK-1). LPS evoked a
similar release of TNFα in WT and P2Y13 KO brain slices, which was
independent of the presence of ATP (Figure 5b), indicating that P2Y13
receptors do not regulate the production of TNFα by microglia.
To further investigate the impact of P2Y13 receptor deletion on
the functional state of microglia in the intact brain, we evaluated the
mRNA expression of selected microglial target genes in whole brains
from P2Y13 KO mice and aged-matched WT controls by RT-PCR. Tar-
get genes were selected according to their expression level in differ-
ent functional states of microglia and were classified as being
F IGURE 5 P2Y13 KO increases baseline release of interleukin 1β in brain slices, however, the microglia in the intact P2Y13 KO brains are not
detectably activated. (a) ELISA-measured IL-1β levels released from hippocampal slices from 8 WT (at P56–P93) and 8 P2Y13 KO mice (at P58–
P105) exposed to no drugs, LPS (50 μg/ml), ATP (1 mM), or ATP + LPS, showing an enhanced resting level of IL-1β release in the KO. (b) ELISA-
measured TNFα levels released from hippocampal slices from 3 WT and 3 P2Y13 KO mice exposed to the same protocol as (a), showing a lack of
effect of knocking out P2Y13 receptors on TNFα release. (c-d) mRNA levels of selected “activation” (il6, il-1β, iNos), “priming” (tlr2, csf1, lgals3), and
“homeostasis” (p2ry12) marker genes in whole brain samples from 5 WT (at P64-P115, 4 males, 1 female) and P2Y13 KO mice (at P62–P115,
4 males, 2 females), relative to Gapdh, as measured by quantitative RT-PCR. (e) Transcript levels of the selected markers shown in c and d in
P2Y13 KO brains expressed as n-fold change relative to their WT aged-matched controls. The number of mice is shown on bars
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associated with “activation” (il1b, il6, iNos), “priming” (tlr2, lgals3, tlr2),
or “homeostasis” (p2ry12), following Holtman et al. (2015). The mRNA
expression of all the genes tested by this method was not different in
P2Y13 KO mice (Figure 5c–e). Thus, our results show that P2Y13
receptors suppress the release of IL-1β in brain slices, however, micro-
glial cells lacking P2Y13 receptors were not detectably activated.
4 | DISCUSSION
P2Y12 and P2Y13 receptors are both highly expressed in microglia at
the mRNA level (Zhang et al., 2014), both use ADP as their preferred
physiological agonist with an EC50 value of ~60 nM (see overview in
Abbracchio et al., 2006) and share a similar pharmacological profile
(Zhang et al., 2002). Both receptors couple predominantly to Gαi pro-
teins and so their activation will inhibit the adenylate cyclase and thus
decrease intracellular cAMP levels. P2Y12 activation has been shown
to mediate directed motility of microglial processes to an ATP/ADP
source (Haynes et al., 2006), but the function of microglial P2Y13
receptors is unknown.
We took advantage of the existence of a P2Y13 receptor knock-
out mouse (Fabre et al., 2010) to investigate the role of this receptor
in microglial function. Although P2Y13 is highly expressed at the
mRNA level in microglia (Stefani et al., 2018; Zhang et al., 2014), its
function has been little studied. This partly reflects a lack of specific
pharmacological tools to activate or inhibit this receptor. MRS 2211 is
often used as a “specific” P2Y13 receptor blocker, but we found that it
affected microglia even when P2Y13 receptors were knocked out, thus
implying that it is not a specific tool to study the role of P2Y13 recep-
tors in any tissue. Haynes et al. (2006) and Stefani et al. (2018) found
that, despite confirming P2Y13 mRNA expression in microglia (Zhang
et al., 2014), its expression could not be detected at the protein level.
The inability to antibody-label P2Y13 may reflect a high rate of consti-
tutive proteasomal degradation (Pons et al., 2014), or may alterna-
tively suggest that P2Y13 protein is only expressed at high levels in
microglial culture (Quintas, Vale, Goncalves, & Queiroz, 2018) or upon
microglial activation in situ (Niu et al., 2017).
We found that knock-out of P2Y13 receptors had four main effects
on microglia. (a) It reduced their ramification (Figure 1) which conse-
quently reduced their surveillance of the brain parenchyma. (b) It
enhanced the outward THIK-1 K+ current evoked by ADP activating
P2Y12 receptors. This is mediated by an increased coupling of P2Y12
receptors to THIK-1 channels (and not an increased number of THIK-1
channels) since the tonic activity of THIK-1 and thus the resting poten-
tial was not changed (Figure 3). (c) Surprisingly, despite the potentiation
of P2Y12 receptor function as assessed by ADP-evoked THIK-1 activa-
tion, the time needed for P2Y12 receptor-mediated convergence of
microglial processes to an ADP source or to local injury triggered by a
laser ablation was prolonged in the P2Y13 KO (Figure 4). (d) The release
of the pro-inflammatory cytokine IL-1β was increased in the P2Y13 KO
in the absence of stimulation with LPS and ATP (Figure 5), suggesting
the adoption of a different functional state with some resemblance to
mild activation, although microglial cells were not detectably activated
as judged by the lack of expression of classical microglial activation
markers (Figure 5). Thus, P2Y13 contributes to maintaining microglial
morphology and surveillance and suppresses inappropriate IL-1β release.
The attraction of microglial processes to an ATP source or laser
lesion involves activation of P2Y12 receptors by ADP (Haynes et al.,
2006) and is independent of THIK-1 activity (Madry, Kyrargyri, et al.,
2018). P2Y12 receptor protein levels were not changed in the P2Y13
KO (at least at the level of the whole brain: Figure S5) and the P2Y13
KO microglia show an enhanced THIK-1 K+ current (Figure 3) evoked
by ADP (Madry, Kyrargyri, et al., 2018), which suggests that the sensi-
tivity of the P2Y13 KO cells to an ADP source is increased. This
increase may reflect more trafficking to the membrane of P2Y12
receptors in the P2Y13 KO, better coupling of P2Y12 to THIK-1 in the
absence of P2Y13, or alternatively an effect of the increase of intracel-
lular cyclic AMP level (e.g., altering phosphorylation and potentiating
P2Y12 action) expected when the Gi-coupled P2Y13 is knocked out
(assuming that there is constitutive activity of P2Y13, which is not
known). This is in line with our data showing that an elevation of
cAMP levels, either by applying forskolin to WT slices or perfusing
cAMP intracellularly via the patch-clamp solution, causes WT micro-
glial cells to adopt features seen in P2Y13 KO microglia, such as
reduced surveillance and ramification (consistent with Bernier et al.,
2019), and a larger P2Y12-activated THIK-1 current (Figure S2b).
Despite this increased sensitivity to ADP, the P2Y13 KO cells moved
their processes at a similar speed to those of the WT towards an ADP
source, where they nevertheless arrived later because the KO cells
are less ramified and have shorter processes, and thus they have to
grow further than the WT cell processes until they reach their target.
Previously we have shown that, in nonactivated microglia, ramifi-
cation is controlled by the cell's membrane potential, so that microglia
become less ramified when the cell is depolarized (Madry, Arancibia-
Cárcamo, et al., 2018; Madry, Kyrargyri, et al., 2018). The loss of rami-
fication seen upon deleting P2Y13 cannot be explained in this way
because the resting potential of the cells was unchanged (Figure 3e),
and may arise from the fact that the microglia have adopted a differ-
ent functional state (Norden & Godbout, 2013; Perry & Holmes,
2014). RT-PCR analysis of the two genotypes at the whole-brain level
did not reveal differences of the activation state of P2Y13 KO
microglia (Figure 5c,e), but this may reflect a lack of sensitivity of the
assay. The fact that more IL-1β protein is released in the P2Y13 KO
(Figure 5a), while the mRNA level for il-1β is unchanged (Figure 5c,e)
may reflect a poor correlation between changes of protein level and
transcriptional, translational, and post-translational processes, which
has previously been described across different systems, conditions,
and developmental stages (Liu, Beyer, & Aebersold, 2016; Peshkin
et al., 2015; Taniguchi et al., 2010).
We suggest above that some of the effects of P2Y13 deletion may
reflect an increase of cAMP concentration in the cell, but other signal-
ing pathways may also be associated with the P2Y13 receptor. These
include Gq-coupled elevations of intracellular [Ca
2+] mediated by
internal store release and activation of store-operated calcium chan-
nels (Carrasquero et al., 2009; Zeng et al., 2014), Erk1/2 activation
(Ortega, Perez-Sen, Delicado, & Teresa Miras-Portugal, 2011), and
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regulation of transcription through a rise in nuclear calcium level and
activation of nuclear factor erythroid-derived 2-like 2, a transcription
factor that regulates the oxidative stress response (Espada et al.,
2010; Lyubchenko et al., 2011). P2Y13 may also inhibit Akt
(Chatterjee & Sparks, 2012), which is an important mediator of P2Y12-
mediated actin re-organization. In addition, the levels of P2Y13 may
directly influence the levels of other purinergic receptors found at the
microglial membrane due to the influence that dimerization between
different P1/P2 receptors can have on receptor trafficking and reten-
tion at the cell surface (Schicker et al., 2009). However, much of the
evidence pertaining to the downstream signaling pathways associated
with P2Y13 should be interpreted with caution, especially in microglia,
for the following reasons. First, many studies were conducted in cell
types other than microglia, or in cell lines or cultured cells, and there
may be differences in the signaling between cell types. Second, almost
all of these studies relied highly upon the use of MRS 2211 to block
P2Y13 receptors, but we have now shown this is not a selective P2Y13
antagonist. Furthermore, the failure, to date, to demonstrate micro-
glial P2Y13 protein expression in vivo suggests either that the com-
mercially available P2Y13 antibodies lack specificity or that the
constitutive proteasomal degradation of the receptor shown to regu-
late the surface expression of the receptor in hepatocytes (Pons et al.,
2014) also happens in microglia in vivo (which would imply that a low
level of surface receptors can still have a significant effect on cell
function).
The high mRNA expression level for P2Y13 in microglia, and the
P2Y13 KO-evoked effects on microglial function that we have charac-
terized, both suggest that P2Y13 plays a direct role in regulating micro-
glial function. Our finding that knocking out P2Y13 receptors results in
less ramified microglia in the brain under resting conditions is in line
with recent studies showing a general reduction in the structural com-
plexity of microglia in P2Y13 KO mice (Stefani et al., 2018) and in mice
with constitutive deletion of the ATP degrading enzymes CD39 and
CD73 (which prevents hydrolysis of extracellular ATP and thus the
formation of the P2Y13 receptor agonist ADP; Matyash et al., 2017).
Nevertheless, the P2Y13 knock-out mouse that has been used is a
global KO, and so the effects seen could in principle be mediated by a
loss of P2Y13 elsewhere in the body. Expression of P2Y13 receptor
mRNA occurs not only in the brain, but also in the liver, spleen, lymph
nodes, and bone (Communi et al., 2001). P2Y13 KO mice show a
decrease in hepatic high-density lipoprotein (HDL) uptake, hepatic
cholesterol content, and biliary cholesterol output, although their
plasma HDL and other lipid levels are normal (Fabre et al., 2010).
These metabolic changes result in a substantial decrease in the rate of
macrophage-to-feces reverse cholesterol transport (RCT), a process
whereby excess peripheral cholesterol, especially that in macrophage
foam cells, is taken up to be incorporated into HDL particles and deliv-
ered to the liver for excretion in the feces. Thus, although it has not
yet been studied, a rise in microglial cholesterol level might occur as a
result of these peripheral changes. Since cholesterol levels regulate
microglial function (Bohlen et al., 2017) and high cholesterol is
reported to lead to microglial activation (Zatta, Zambenedetti, Stella, &
Licastro, 2002), it is conceivable that the effects we report are
mediated by altered systemic cholesterol trafficking. Construction of a
microglial-specific P2Y13 receptor KO mouse will help further investi-
gations of the role of P2Y13 receptors in microglia, without interfer-
ence from the actions of this receptor in peripheral tissues.
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